AIXC Company Profile and Key Details

Short-term trend indicators are bullishly aligned (SMA20 -14.01%, SMA50 -41.87%, SMA200 -58.42%). The stock’s 14-day RSI is 34.32 (weak momentum), while the ATR of 0.16 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -86.61% below its high and over 28.26% above its low. Average 10-day trading volume of 28.17 thousand shares is below the 3-month average of 63.22 thousand, indicating normal recent market interest.

AIxCrypto Holdings, Inc. generated EPS of -$8.66 over the past year. Five-year average earnings growth is 79.32%. AIxCrypto Holdings, Inc. earnings surprise history is a mixed track record. The quarter that ended March 24, 2026, missed forecasts by -94.63%.

AIxCrypto Holdings, Inc. has 22.16 million shares outstanding. The public float is 18.56 million shares, elevated short interest at 0.52% of float. This equals 115.92 thousand shares. The short ratio is 1.96 days. Institutional investors hold 0.58% of the float. Insiders own 20.08%.

AIxCrypto Holdings, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $3.25. This means the shares are trading below this model’s fair value.

AIxCrypto Holdings, Inc. (NASDAQ:AIXC) closed at $1.38 USD, losing -$0.06 (-4.17%) from the previous close of $1.44. The stock is currently mid-range between its 52-week high and low $0.92 and $8.81. With a market capitalization of about $7.12 million, AIxCrypto Holdings, Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~0.52). Key stats such as the average daily volume over the past year has been around 62.23 thousand shares, volume is running light vs its 52-week average. Headquartered in Carlsbad, CA, AIxCrypto Holdings, Inc. operates in the Healthcare sector and the Medical - Pharmaceuticals industry. Led by CEO Kevin A. Richardson, the company employs approximately 4 people and listed since June 23, 2015. AIxCrypto Holdings, Inc., a clinical-stage therapeutics company, focuses on the development of treatments for adult and pediatric cancer.

Our AI price prediction model suggests that AIxCrypto Holdings, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 5.07%, with price expected at $1.45 by May 21, 2026, within a range of $1.36 to $1.54 3-Month Outlook: Projected fall of -94.93%, reaching $0.07 by August 05, 2026, with a range of $0.04 to $0.09. 1-Year Outlook: Projected loss of -94.2%, with price at $0.08 by May 07, 2027, within a range of $0.06 to $0.11.

AIxCrypto Holdings, Inc. (NASDAQ:AIXC) shares are flat -0.43% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows AIxCrypto Holdings, Inc. trading at a premium to the broader market with a P/E of -0.27. Our AI forecast model points to short-term strength (5.07% over two weeks), a medium-term fall (-94.93% over three months), and a longer-term loss (-94.2% over one year), with expected trading ranges indicating moderate volatility.

AIxCrypto Holdings, Inc. trades at a P/E ratio of -0.27, slightly below the S&P 500 average, with a price-to-sales ratio of 0.0 and a price-to-book ratio of 0.17 suggesting the stock is closer to book value. The P/FCF stands at -1.05, also below market averages.